Practice
Featured experience
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
Amer Sports $1.3 billion secondary offering
We advised Amer Sports on its SEC-registered secondary offering of ordinary shares
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Emerson $3 billion sale of InSinkErator business to Whirlpool
We are advising Emerson on the transaction
Gilead Sciences $405 million acquisition of MiroBio
We are advising Gilead Sciences on the transaction
CSX $2 billion senior notes offering
We advised CSX on the investment-grade debt offering
Morgan Stanley $4 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Tuya global offering and dual primary listing on the Hong Kong Stock Exchange
We advised Tuya Inc. on its HK$141 million global offering and dual primary listing on the HKEX
Dufry combination with Autogrill
We are advising Dufry on the transaction
Baker Hughes sale of Nexus Controls to GE Gas Power
We are advising Baker Hughes on the transaction
NatWest Group $1 billion senior notes offering
We advised NatWest Group on the SEC-registered offering
Precigen sale of Trans Ova Genetics to URUS
We are advising Precigen on the transaction
Acutus Medical sale of its left-heart access portfolio products and refinancing
We advised Acutus Medical on the transactions